ESMO Therapeutic Landscapes Webinar Series is designed for oncology professionals seeking a deeper understanding of today’s rapidly evolving therapeutic environment
With a broad and inclusive focus, this series explores the latest scientific advances and clinical practices in oncology. From molecular insights to novel systemic therapies, each session highlights the state of the art care pathways, including recent breakthroughs, across cancer types.
ABOUT THE WEBINAR SERIES
Explores the latest scientific advances and clinical practices in oncology
The faculty consists of three speakers, identified as leading experts in the specific area
Each 60 minute webinar includes interactive, live presentations, discussion and Q&A
Webinars take place on a Wednesday through the ESMO On Air initiative
This webinar series is multi-sponsored per series
ESMO THERAPEUTIC LANDSCAPES WEBINAR SERIES 2026: ANTIBODY-DRUG CONJUGATES (ADCS)
Next Generation Antibody-Drug Conjugates: Technological Advances, Drug Development and Combination Strategies
27 MAY 2026
Giuseppe Curigliano
Italy (Chair)
Next-Generation Antibody-Drug Conjugates: Technological Advances, Drug Development and Combination Strategies
8 JULY 2026
TBC TBC
TBC (Co-Chair)
Optimising Antibody-Drug Conjugate Safety: Mechanisms, Monitoring and Management of Toxicities
9 SEPTEMBER 2026
Liliana Ascione
Italy (Co-Chair)
FUNDING OPTIONS
Support type
Funding amount per sponsor (EUR)
Multi-sponsored
€50,000 Per series of 3 webinars
BENEFITS FOR OUR PARTNERS
EXTENSIVE COMPANY/LOGO RECOGNITION
WEBINAR HOSTED ON-DEMAND ON ONCOLOGYPRO FOR 2 YEARS
FULL OUTCOMES REPORT INCLUDING LIVE AND ON-DEMAND METRICS